ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

Scientific Session 3: The Microenvironment and Mechanisms of Transformation
11:41

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Loss of Function of the SETD2 Tumor Suppressor is a Recurrent Event in Advanced-phase Chronic Myeloid Leukemia, is Due to Post-translational Mechanisms and Fosters Genetic Instability

FEATURING Manuela Mancini
  • 5 views
  • January 2, 2019
17:28

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

CML Hematopoietic Stem Cells Expressing IL-1RAP May be Targets of Chimeric Antigen Receptor (CAR) - Engineered T-cells

FEATURING Christophe Ferrand
  • 17 views
  • January 2, 2019